Item

Description

Owner

Item

Discussion/Actions

1

Welcome and role call

BGO, all

2

Review of SHR project as it relates to allergens

TMO

AllergyCRS-Substance-Drug-Update-2017-09-07.docx

3

Review of questions raised by @Marie-Alexandra Lambot with responses

BGO, all

SCT allergy group - questions lma_responses BG-TMOComments.docx

• @Bruce Goldberg to create CRS requests based on content requirements

• @Marie-Alexandra Lambot to send to @Bruce Goldberg additional sulfite substances

• How to represent allergy to adhesive bandage as a physical object vs. product has not been resolved

4

Pseudoallergy

BGO

• The term "pseudoallergy" is obsolete as discrete pathophysiologic mechanisms have been identified. Recommendation is to replace with non-allergic hypersensitivity which will align more closely with WAO/EAAAI nomenclature 

• General agreement on retiring current pseudoallergy concepts with nonallergic hypersensitivity and retaining pseudoallergy as a synonym.

• General agreement with proposed model for organizing nonallergic hypersensitivity by mechanism using discrete nonallergic hypersensitivity process subtypes.

• Unresolved discussion as to whether intolerance is a subtype of nonallergic hypersensitivity or the same as nonallergic hypersensitivity

  • Should definition of non-allergic hypersensitivity include ...symptoms resembling allergy....?

Debates in allergy medicine.pdf

5

Adjourn

BGO

• Next meeting October 5, 2017, 20:00 UTC

• Please submit topics for next call